| Financial Year |
March 31 2023 |
| Monetary Funds |
672,057,745.11 |
| Held-for-trading Financial Assets |
166,803,373.98 |
| Notes Receivable |
-- |
| Accounts Receivable |
205,684,218.26 |
| Advances to Suppliers |
91,534,453.41 |
| Other Receivables |
60,340,958.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,980,331,489.18 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
125,618,592.36 |
| Total Current Assets |
3,331,317,958.65 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
73,692,774.39 |
| Investment Properties |
146,926,206.37 |
| Fixed Assetes |
295,700,529.96 |
| Under-construction Projects |
16,882,809.44 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
14,483,752.70 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
44,761,093.07 |
| R&D expenses |
-- |
| Goodwill |
48,411,578.13 |
| Long-Term Deferred and Prepaid Expenses |
887,967.25 |
| Deferred Income Tax Assets |
17,925,074.39 |
| Other Non-Current Assets |
58,683,835.65 |
| Sub-Total of Non-Current Assets |
785,658,949.60 |
| Total Assets |
4,116,976,908.25 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
36,800,000.00 |
| Accounts Payable |
312,904,289.98 |
| Accounts Received In Advance |
59,226.00 |
| Employee Compensation Payable |
6,273,044.17 |
| Taxes Payable |
19,861,411.45 |
| Interest Payable |
-- |
| Dividend Payable |
3,413,335.10 |
| Other payables |
200,490,319.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
263,316,728.35 |
| Other Current Liabilities |
80,128,582.84 |
| Sub-Total of Current Liabilities |
1,812,757,112.50 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
3,277,161.53 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
361,897.90 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
24,785,956.55 |
| Total Liabilities |
1,837,543,069.05 |
| Paid-In Capital(Or Share Stock) |
1,931,780,892.00 |
| Capital Surplus |
1,419,409,561.76 |
| Surplus Reserve |
33,035,032.64 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,019,634,786.33 |
| Minority Stockholder's Interest |
-85,156,860.87 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,364,590,700.07 |
| Owner's Equity（Stockholder's Equity） |
2,279,433,839.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,116,976,908.25 |
